Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study

BACKGROUND: The efficacy of fixed-dose combinations (FDCs) in improving adherence and risk factor control for cardiovascular disease has not been reported consistently. Here, we compared adherence and efficacy between an olmesartan/rosuvastatin FDC and the usual regimen. METHODS: In this 6-month, op...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Seyong, Ko, Young-Guk, Kim, Jung Sun, Kim, Byeong-Keuk, Ahn, Chul-Min, Park, Sungha, Hong, Sung-Jin, Lee, Sang-Hak, Choi, Donghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550343/
https://www.ncbi.nlm.nih.gov/pubmed/33346375
http://dx.doi.org/10.5603/CJ.a2020.0167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550343/
https://www.ncbi.nlm.nih.gov/pubmed/33346375
http://dx.doi.org/10.5603/CJ.a2020.0167

Ejemplares similares